Myeloproliferative Neoplasms

Test Your Knowledge

11/11/2021

Which of the following mutations was identified as a high-risk bleeding factor in MPN?

Which of the following mutations...

11/11/2021

Oncology

Videos

12/15/2019

Dr Zeidan discusses results from a study of azacitidine plus durvalumab in older patients with AML and high-risk MDS unfit for intensive chemo.

Dr Zeidan discusses results from...

12/15/2019

Oncology

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19